3.53
price up icon0.86%   0.03
after-market Handel nachbörslich: 3.53
loading

Finanzdaten der Atea Pharmaceuticals Inc-Aktie (AVIR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
5.90%
41.34
39.04 39.03 37.20 46.92
Depreciation and Amortization
0.00%
0.104
0.104 0.104 0.104 0.104
Operating Income/Loss
5.90%
-41.34
-39.04 -39.03 -37.20 -46.92
Income/Loss From Continuing Operations Before Tax
8.47%
-36.95
-34.07 -33.32 -30.93 -40.28
Income Tax Expense/Benefit
1.97%
0.207
0.203 0.225 0.226 0.243
Income/Loss From Continuing Operations After Tax
8.43%
-37.16
-34.27 -33.54 -31.15 -40.52
Net Income/Loss
8.43%
-37.16
-34.27 -33.54 -31.15 -40.52
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.66%
83.75
85.16 0.0666 84.42 84.25
Diluted Average Shares
1.66%
83.75
85.16 0.0666 84.42 84.25
Basic Earnings Per Share
10.00%
-0.44
-0.40 -0.40 -0.37 -0.48
Diluted Earnings Per Share
10.00%
-0.44
-0.40 -0.40 -0.37 -0.48
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$36.31
price down icon 1.55%
$86.53
price up icon 0.38%
$26.01
price up icon 0.54%
$110.77
price down icon 0.48%
$132.60
price up icon 2.43%
biotechnology ONC
$313.97
price up icon 1.50%
Kapitalisierung:     |  Volumen (24h):